Impact of first- and second-line treatment for Hodgkin's lymphoma on the incidence of AML/MDS and NHL--experience of the German Hodgkin's Lymphoma Study Group analyzed by a parametric model of carcinogenesis. [electronic resource]
Producer: 20110614Description: 681-688 p. digitalISSN:- 1569-8041
- Algorithms
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Bleomycin -- adverse effects
- Cyclophosphamide -- adverse effects
- Dacarbazine -- adverse effects
- Doxorubicin -- adverse effects
- Etoposide -- adverse effects
- Glyoxal -- adverse effects
- Hodgkin Disease -- drug therapy
- Humans
- Ifosfamide -- adverse effects
- Kaplan-Meier Estimate
- Leukemia, Myeloid, Acute -- chemically induced
- Lymphoma, Non-Hodgkin -- chemically induced
- Myelodysplastic Syndromes -- chemically induced
- Neoplasms, Second Primary -- chemically induced
- Prednimustine -- adverse effects
- Prednisone -- adverse effects
- Procarbazine -- adverse effects
- Proportional Hazards Models
- Randomized Controlled Trials as Topic
- Risk Assessment
- Treatment Outcome
- Vinblastine -- adverse effects
- Vincristine -- adverse effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.